Réunion Clinical Trials

• A Phase II Study of Abatacept Versus Placebo to Assess the Prevention of Rheumatoid Arthritis (RA) in Adult Patients with Undifferentiated Arthritis Who Are at High Risk for the Development of RA.
  ClinicalTrials.gov Identifier: NCT00124449 - Active, not recruiting
  Arthritis, Rheumatoid
  
• A Prospective Randomised Controlled Trial on the Use of BMP-7 (OP-1®) and Demineralised Bone Matrix in Tibial Non-Union
  ClinicalTrials.gov Identifier: NCT00551941 - Recruiting
  Non-Union Diaphysary Tibial Fractures
  
• An Analysis of Peripheral Blood T Cell Subsets on RA
  ClinicalTrials.gov Identifier: NCT00555542 - Active, not recruiting
  Rheumatoid Arthritis
  
• Assessment of Safety, Pharmacokinetics and Efficacy in a Combination Treatment With SMP-114
  ClinicalTrials.gov Identifier: NCT00296257 - Active, not recruiting
  Rheumatoid Arthritis (RA)
  
• Open Label, Dose-Regimen Study Evaluating Etanercept 50 mg Once-Weekly In Japanese Subjects With RA
  ClinicalTrials.gov Identifier: NCT00418717 - Active, not recruiting
  Arthritis, Rheumatoid
  
• Efficacy, Safety, Immunogenicity and Effect on Immune Response of Adalimumab Following Subcutaneous Administration in Patients With Active RA Treated Concomitantly With MTX.
  ClinicalTrials.gov Identifier: NCT00195702 - Active, not recruiting
  Rheumatoid Arthritis
  
• Multicenter Active RA Study
  ClinicalTrials.gov Identifier: NCT00551707 - Recruiting
  Rheumatoid Arthritis
  
• A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy
  ClinicalTrials.gov Identifier: NCT00316771 - Active, not recruiting
  Rheumatoid Arthritis
  
• A Study of Retreatment With MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
  ClinicalTrials.gov Identifier: NCT00422383 - Active, not recruiting
  Rheumatoid Arthritis
  
• Develop Biomarkers for Assessing RA Joint Erosion
  ClinicalTrials.gov Identifier: NCT00154947 - Active, not recruiting
  Rheumatoid Arthritis
  
• A Drug Use Investigation of ENBREL for Post-Marketing Surveillance (PMS) for RA and PsA
  ClinicalTrials.gov Identifier: NCT00195403 - Recruiting
  Rheumatoid Arthritis
  
• Long-Term Assessment of Safety and Physical Function With AMG 108 in RA
  ClinicalTrials.gov Identifier: NCT00369473 - Recruiting
  Rheumatoid Arthritis
  
• Induction of Remission in RA Patients at Low Disease Activity by Additional Infliximab Therapy (Study P04644AM1)
  ClinicalTrials.gov Identifier: NCT00521924 - Recruiting
  Rheumatoid Arthritis
  
• A Study to Observe Safety and Effectiveness of MRA (Tocilizumab) Compared to Methotrexate (MTX) alone for Patients with Active Rheumatoid Arthritis (RA)
  ClinicalTrials.gov Identifier: NCT00109408 - Active, not recruiting
  Rheumatoid Arthritis
  
• Study Evaluating Etanercept in Patients With Rheumatoid Arthritis(RA), Juvenile Idiopathic Arthritis (JIA), or Psoriatic Arthritis (PsA) in Spain
  ClinicalTrials.gov Identifier: NCT00195377 - Active, not recruiting
  Arthritis, Psoriatic; Arthritis, Rheumatoid
  
• Role of DcR3 in T Cell Activation in SLE and RA
  ClinicalTrials.gov Identifier: NCT00275899 - Recruiting
  SLE; Rheumatoid Arthritis
  
• PSRand MFG-E8 Polymorphism in RA and SLE
  ClinicalTrials.gov Identifier: NCT00364728 - Recruiting
  SLE; Rheumatoid Arthritis; Healthy Subjects
  
• Study of MRA in Patients with Rheumatoid Arthritis(RA)
  ClinicalTrials.gov Identifier: NCT00144651 - Active, not recruiting
  Rheumatoid Arthritis
  
• Long-Term Treatment Study of MRA for Rheumatoid Arthritis(RA) from Study MRA220JP or MRA221JP
  ClinicalTrials.gov Identifier: NCT00144586 - Active, not recruiting
  Rheumatoid Arthritis
  
• Long-Term Treatment Study of MRA for Rheumatoid Arthritis(RA) from Study MRA012JP
  ClinicalTrials.gov Identifier: NCT00144547 - Active, not recruiting
  Rheumatoid Arthritis
  
• Long-Term Treatment Study of MRA for Rheumatoid Arthritis(RA) from Study MRA213JP
  ClinicalTrials.gov Identifier: NCT00144534 - Active, not recruiting
  Rheumatoid Arthritis
  
• FK506 Phase 4 Study: A Double Blind Placebo Controlled Study to Assess the Efficacy on Joint Damage in RA Patients
  ClinicalTrials.gov Identifier: NCT00319917 - Recruiting
  Rheumatoid Arthritis
  
• Evaluation of 2 Oral Doses of PG-760564 in Rheumatoid Arthritis (RA) Patients Receiving Methotrexate
  ClinicalTrials.gov Identifier: NCT00369928 - Recruiting
  Rheumatoid Arthritis
  
• A Pharmacokinetic and Pharmacodynamic Study of MabThera (Rituximab) Plus Methotrexate in Patients With Rheumatoid Arthritis (RA)
  ClinicalTrials.gov Identifier: NCT00422942 - Recruiting
  Rheumatoid Arthritis
  
• A Phase II Dose-Finding Study of Atacicept in Rheumatoid Arthritis (RA)
  ClinicalTrials.gov Identifier: NCT00430495 - Recruiting
  Rheumatoid Arthritis
  
• Abatacept Subcutaneous Bridging Study
  ClinicalTrials.gov Identifier: NCT00559585 - Not yet recruiting
  Rheumatoid Arthritis (RA)
  
• PhaseⅢOpen-Label Study of MRA for Rheumatoid Arthritis(RA)
  ClinicalTrials.gov Identifier: NCT00380601 - Recruiting
  Rheumatoid Arthritis
  
• Phase IIIB Subcutaneous Abatacept Monotherapy Study
  ClinicalTrials.gov Identifier: NCT00547521 - Not yet recruiting
  Rheumatoid Arthritis (RA)
  
• Dosing Flexibility Study in Patients With RA EXTEND TRIAL
  ClinicalTrials.gov Identifier: NCT00580840 - Not yet recruiting
  Rheumatoid Arthritis
  
• A Rheumatoid Arthritis (RA) Study Treating Signs and Symptoms of RA in People With RA & Receiving Methotrexate
  ClinicalTrials.gov Identifier: NCT00038298 - Terminated
  Arthritis, Rheumatoid
  
• Réa-MiniMax: Severe Acute Respiratory Failure in Hematology and Cancer Patients Without Bronchoalveolar Lavage
  ClinicalTrials.gov Identifier: NCT00248443 - Recruiting
  Lymphoma; Cancer; Acute Respiratory Failure; Leukemia
  
• Decoy Receptor 3 (DcR3) Polymorphisms in Rheumatoid Arthritis (RA) and Systemic Lupus Erythematosus (SLE)
  ClinicalTrials.gov Identifier: NCT00172666 - Recruiting
  Rheumatoid Arthritis; Systemic Lupus Erythematosus
  
• Clinical Study of the U-Plate Fracture Repair System to Treat Rib Fractures
  ClinicalTrials.gov Identifier: NCT00556543 - Recruiting
  Rib Fracture; Flail Chest; Rib Fracture Non-Union; Chest Wall Deformity
  
• Efficiency and Tolerance of Rituximab (mabthéra) in Bullous Pemphigoid
  ClinicalTrials.gov Identifier: NCT00525616 - Not yet recruiting
  Bullous Pemphigoid
  
• Etanercept SFP in RA Patients
  ClinicalTrials.gov Identifier: NCT00413452 - Completed
  Rheumatoid Arthritis
  
• Study to Assess Steady-State Trough Concentrations, Safety, and Immunogenicity of Abatacept After SC Administration to Subjects With RA
  ClinicalTrials.gov Identifier: NCT00254293 - Completed
  Rheumatoid Arthritis
  
• Treatment of Early RA: Minocycline in Combination With Methotrexate vs Methotrexate Alone
  ClinicalTrials.gov Identifier: NCT00579644 - Completed
  Rheumatoid Arthritis
  
• Study Of 90mg Of GW274150 In Subjects Over 50 Years, Who Have Rheumatoid Arthritis (RA)
  ClinicalTrials.gov Identifier: NCT00370435 - Completed
  Rheumatoid Arthritis
  
• Feasibility Study of Aastrom Tissue Repair Cells to Treat Non-Union Fractures.
  ClinicalTrials.gov Identifier: NCT00424567 - Completed
  Fracture, Ununited; Pseudarthrosis
  
• A Study to Evaluate the Safety of an Investigational Drug (Etoricoxib) in Patients With Osteoarthritis (OA) or Rheumatoid Arthritis (RA)
  ClinicalTrials.gov Identifier: NCT00250445 - Completed
  Rheumatoid Arthritis,Osteoarthritis
  
• Treatment for Subjects with Active Rheumatoid Arthritis (RA)
  ClinicalTrials.gov Identifier: NCT00110903 - Completed
  Rheumatoid Arthritis
  
• A Multicentre Trial to Determine the Efficacy of AD 452 in RA Subjects.
  ClinicalTrials.gov Identifier: NCT00141934 - Completed
  Rheumatoid Arthritis
  
• Study of LymphoStat-B (monoclonal anti-BLyS antibody) in Subjects with Rheumatoid Arthritis (RA)
  ClinicalTrials.gov Identifier: NCT00071812 - Completed
  Arthritis, Rheumatoid
  
• Clinical Pharmacology Study of MRA in Patient with Rheumatoid Arthritis(RA) with Renal Impairment
  ClinicalTrials.gov Identifier: NCT00144573 - Completed
  Rheumatoid Arthritis
  
• Single Dose Study Of GW856553 On A Protein That Is An Indicator For Rheumatoid Arthritis(RA)
  ClinicalTrials.gov Identifier: NCT00256919 - Completed
  Rheumatoid Arthritis
  
• Anakinra (Kineret®) in Combination with Disease Modifying Anti-Rheumatic Drugs (DMARDS) in Subjects with Active Rheumatoid Arthritis (RA)
  ClinicalTrials.gov Identifier: NCT00117091 - Completed
  Rheumatoid Arthritis
  
• Preference of Rheumatoid Arthritis (RA) Patients of Enbrel® (etanercept) Auto-Injector versus Enbrel® Pre-Filled Syringes
  ClinicalTrials.gov Identifier: NCT00094341 - Completed
  Rheumatoid Arthritis
  
• Evaluating the Effect of Anakinra (r-metHuIL-1ra) on Vaccine Antibody Response in Subjects with Rheumatoid Arthritis (RA)
  ClinicalTrials.gov Identifier: NCT00111410 - Completed
  Rheumatoid Arthritis
  
• Evaluating Kineret® (Anakinra) in Rheumatoid Arthritis (RA) Subjects Using a Self-Reported Questionnaire
  ClinicalTrials.gov Identifier: NCT00121043 - Completed
  Rheumatoid Arthritis
  
• Drug-Drug Interaction Study of MRA in Patient with Rheumatoid Arthritis(RA)
  ClinicalTrials.gov Identifier: NCT00144560 - Completed
  Rheumatoid Arthritis
  
• Phase III Comparative Study(Double-Blind) of MRA for Rheumatoid Arthritis(RA)
  ClinicalTrials.gov Identifier: NCT00144521 - Completed
  Rheumatoid Arthritis
  
• Phase III Comparative Study(Open-Label) of MRA for Rheumatoid Arthritis(RA)
  ClinicalTrials.gov Identifier: NCT00144508 - Completed
  Rheumatoid Arthritis
  
• Evaluating the Safety of Extended Treatment with Pegsunercept (PEG sTNF-RI) in Subjects with Rheumatoid Arthritis (RA)
  ClinicalTrials.gov Identifier: NCT00111423 - Completed
  Rheumatoid Arthritis
  
• Evaluating Efficacy and Safety of Etanercept 50 mg Twice Weekly (BIW) in Rheumatoid Arthritis (RA) Subjects who are Sub-Optimal Responders to Etanercept 50 mg Once Weekly (QW)
  ClinicalTrials.gov Identifier: NCT00115219 - Completed
  Rheumatoid Arthritis
  
• Randomized, Double-Blind, Placebo-Controlled Study to Assess Fatigue in Patients With ACD Due to RA Receiving PROCRIT
  ClinicalTrials.gov Identifier: NCT00236678 - Terminated
  Anemia; Rheumatoid Arthritis
  
• Study of Enbrel in RA Subjects with Comorbid Disorders.
  ClinicalTrials.gov Identifier: NCT00132418 - Completed
  rheumatoid arthritis andat least 1 qualifying comorbid condition (diabetes, chronic pulmonary disease, recent infection)